Biochem/physiol Actions
Darunavir has been sanctioned by the food and drug administration (FDA) as the first treatment of drug-resistant human immunodeficiency virus (HIV).
Darunavir is a second-generation antiviral HIV protease inhibitor with broad spectrum activity.
Packaging
10, 50 mg in glass bottle
This product has met the following criteria to qualify for the following awards: